Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company that has developed multiple methods for the manufacturing of various types of gold nanoparticles. The Company is engaged in the research and development of its technology for use in multiplex diagnostic testing platforms and biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery... see more

CSE:SONA - Post Discussion

Sona Nanotech Inc > HC authorization approval
View:
Post by MetalsDude on Nov 03, 2020 10:24am

HC authorization approval

Just a speculation but wouldn't this new director appointment mean that Sona is getting HC approval otherwise why would this guy take on this position and get shares at $3.36. If he didnt already knew approval is imminent? Just a thought.
Comment by Jimc409 on Nov 03, 2020 10:40am
I hope you are correct but it could also be because of SONA's cancer research or the concussion research.
Comment by datawork on Nov 03, 2020 3:01pm
I see little point in bringing him onboard if Sona doesn't foresee HC approval.
Comment by Waco4505 on Nov 03, 2020 5:55pm
Approval is coming 
Comment by Beerzerker on Nov 03, 2020 6:39pm
I wouldn't bet on Sona. They had such a monsterous headstart and now there are 7 antigen tests already approved by FDA (and they are not one). Be smart with your money and go buy scratch tickets or something. Sona is only going down until they have 1. approval, and 2. Sales. Lots of companies with approval, but no sales. This is basically cannabis all over again.
Comment by Kaiser on Jul 22, 2021 1:41am
Here's a thought. You're a disgruntled bag holder. Your post Nov.03.2020 price on that day. Average down big fella.  You can bs all you want but you sure seem butt hurt for a guy who's making money here.   Nov 03, 2020 3.7500 3.6800 3.9200 3.4000 758.09K 11  
Comment by MetalsDude on Jul 22, 2021 8:02am
Disgruntled bag holder? Sure I lost some money on sona but I'll recover what I lost on sona through this stock or some other stock BUT I'm not bashing sona for my own actions..I'm more certain than ever that Kaiser bought in sona at double digits. Probably $15+ that's why he's so mad, who would in their right mind be bashing a stock soo hard if they had no position in???
Comment by MetalsDude on Jul 22, 2021 8:05am
Kaiser claims he has no sona shares...he mad he bought in high and now lost bunch of money. How's that lawsuit going Kaiser? You think you'll get your money back from sona? Lol
Comment by Kaiser on Jul 22, 2021 9:52am
LOL come on man.  Find a post of mine that even mentions me wanting to buy let alone owning shares.  Quit being a clown.   I bought Therma.  You know the covid play that actually HAS a covid test.  Don't be jealous you bet on the wrong horse.   
Comment by Kaiser on Jul 22, 2021 10:15am
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities